Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
May 9, 2022	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-22-013318.pdf 0001628280-22-013318.rtf 0001628280-22-013318.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 4, 2022	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-22-021096.pdf 0001628280-22-021096.rtf 0001628280-22-021096.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 3, 2022	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-22-028242.pdf 0001628280-22-028242.rtf 0001628280-22-028242.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 8, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-23-016258.pdf 0001628280-23-016258.rtf 0001628280-23-016258.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 28, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-23-030698.pdf 0001628280-23-030698.rtf 0001628280-23-030698.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 8, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-23-037557.pdf 0001628280-23-037557.rtf 0001628280-23-037557.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 9, 2024	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-24-021945.pdf 0001628280-24-021945.rtf 0001628280-24-021945.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 15, 2020	PRER14A	Proxy soliciting materials. Revised preliminary material	0001193125-20-107370.pdf 0001193125-20-107370.rtf 0001193125-20-107370.xls View HTML
October 25, 2018	S-4/A	Pre-effective amendment to an S-4 filing	0001193125-18-307890.pdf 0001193125-18-307890.rtf 0001193125-18-307890.xls View HTML
October 29, 2018	S-4/A	Pre-effective amendment to an S-4 filing	0001193125-18-309873.pdf 0001193125-18-309873.rtf 0001193125-18-309873.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax